BIVI · BioVie Inc
United States · RS rating 66 · As of 2026-11-03
| Price | 1.73 USD |
|---|---|
| 1-day change | +26.3% |
| RS rating (overall / 1M / 3M / 12M) | 66 / 93 / 37 / 50 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 39 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +21.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +24.1% |
| Market cap (USD) | $10.8M |